Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14751 - 14775 of 14838 in total
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
Doramapimod is a P38 MAP kinase inhibitor.
Investigational
Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational
Experimental
Investigational
BMS-986141 is under investigation in clinical trial NCT02985632 (A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants).
Investigational
ANA971, an orally administered prodrug of isatoribine. Isatoribine is a nucleoside analog in development for the treatment of chronic hepatitis C virus (HCV) infection. ANA971 is a prodrug designed to improve the oral bioavailability of isatoribine. ANA971 resulted in higher levels of isatoribine in the blood than were present after...
Investigational
A phosphodiesterase inhibitor with antidepressant properties.
Investigational
Experimental
Etamivan (INN) or ethamivan (USAN) is marketed under the name Analepticon. Etamvin is a respiratory stimulant drug similar to nikethamide. It is no longer used in the United States.
Withdrawn
PF-4191834 has been investigated for the basic science of Asthma.
Investigational
Vestipitant has been investigated for the treatment of Tinnitus.
Investigational
Experimental
Displaying drugs 14751 - 14775 of 14838 in total